EL Related Analyst Ratings
-
Estee Lauder (EL) Lower as CLSA Downgrades to Outperform
-
Goldman Sachs Resumes Estee Lauder (EL) at Buy, Citing Secular Trends
-
Morgan Stanley Starts Estee Lauder (EL) at Overweight
-
UPDATE: Barclays Starts "Overweight" Coverage on GNC Corp. (GNC); Typical Buyer: Above-Average Income, Committed to Heathly Lifestyle = Recession Resistant
-
Deutsche Bank on U.S. Beverages and Household/Personal Care Products: Adjusting Estimates on Eight Companies
-
Deutsche Bank Lowers Price Target on Estee Lauder (EL); Q2 Preview: Headwinds Remain
-
Wells Fargo Starts Estee Lauder (EL) at Outperform; Current Price Offers Investors Good Entry Point
-
Caris & Co. Downgrades Estee Lauder (EL) to Above Average
-
Citi Downgrades Estee Lauder (EL) to Neutral
-
Citi Downgrades Estee Lauder (EL) to Neutral
-
UBS Maintains a 'Neutral' on Church & Dwight (CHD); Doing All the Right Things, but We Prefer Estee Lauder (EL)
-
UPDATE - UBS Downgraded Procter & Gamble (PG); The Head is Moving Faster Than The Tail
-
UBS Reiterates a 'Buy' on Estee Lauder (EL); Beyond The Numbers
-
Jefferies Boosts Price Target & Estimates on Estee Lauder (EL) Following Strong Q1 Growth
-
Standpoint Research Starts Avon Products (AVP) at Buy, Sets $25 Price Target
-
Barclays Maintains an 'Overweight' on PepsiCo (PEP); One Door Closes, Another One Opens
-
Stifel Nicolaus Upgrades Estee Lauder (EL) to Buy
-
BofA Upgrades CL, EL to Buy, Downgrades PG to Neutral
-
Jefferies Lowers Price Target on Estee Lauder (EL), Sees Operatign Margin in the 20% Range Looking Ahead
-
Credit Agricole Upgrades Estee Lauder (EL) to Buy
-
BMO Capital Upgrades Estee Lauder (EL) to Outperform
-
Credit Suisse Starts Estee Lauder (EL) at Neutral
-
Weeden & Co Starts Estee Lauder (EL) at Sell
-
Barclays Maintains an 'Overweight' on Estee Lauder (EL); Revenue 'Even Better' Than Margins
-
Wedbush Raises Price Target on Estee Lauder (EL), Solid Restructuring Leads to Improving Margins
-
Barclays on U.S. Consumer Staples: Removing RAH from our Consumer Staples 'Favorites' List
-
Jefferies Boosts Estimates and Price Target on Estee Lauder (EL), Maintains Buy Rating
-
UBS Reiterates a 'Buy' on Estee Lauder (EL); You Get What You Pay For - Growth, Visibility, and Upside Delivery in a Volatile Environment
-
Wedbush Raises Price Target on Estee Lauder (EL), Maintains Outperform Rating
-
UPDATE - UBS Upgraded Estee Lauder (EL) to Buy; Joining a Prestigious Club
-
UBS Upgrades Estee Lauder (EL) to Buy
-
Jefferies Starts Estee Lauder (EL) at Buy, Price Target $90
-
UBS Maintains a 'Neutral' on Estee Lauder (EL); Like What They’re Doing, But Not the Valuation
-
Oppenheimer Upgrades Estee Lauder (EL) to Perform
-
Barclays Upgrades Estee Lauder (EL) to Overweight; More Than Just 'Cosmetic' Change
-
Barclays Downgrades Avon Products (AVP); Upgrades Estee Lauder (EL)
-
Piper Jaffray Downgrades Estee Lauder (EL) to Neutral
-
Barclays Maintains an 'Equalweight' Rating on Estee Lauder (EL); Shifting Estimates
-
Barclays Maintains an 'Equalweight' Rating on Estee Lauder (EL); Where Have All the Savings Gone?
-
Piper Jaffray Reiterates an 'Overweight' Rating on Estee Lauder (EL); Remain Buyers On Weakness
-
Citi Maintains a 'Buy' Rating on Estee Lauder (EL); Remains the Most Exciting Story in the Group
-
Oppenheimer Downgrades Estee Lauder (EL) to Underperform
-
Stifel Nicolaus Downgrades Estee Lauder (EL) to Sell
-
Citi Maintains a 'Buy' on Estee Lauder (EL); Remains Our Favorite Stock for the Longer Term
-
Atlantic Securities Downgrades Estee Lauder (EL) to Neutral
-
UBS Maintains a 'Neutral' Rating on Estée Lauder (EL); Raises PT
-
Caris & Co Upgrades Estee Lauder (EL) to Buy
-
UBS Upgrades Estee Lauder (EL) to Neutral
-
Goldman Removes Estee Lauder (EL) from Conviction Sell List; Upgrades to Neutral
-
Goldman Sachs Upgraded Estee Lauder (EL) from Conviction Sell to Neutral
Back to EL Stock Lookup
